-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 11, the National Pharmacopoeia Commission issued a notice on improving the national drug standards in 2021.
124 drugs and 49 general technical methods were included in the 2021 standard improvement task
.
All relevant units:
In accordance with the "Administrative Measures for the Development and Revision of Drug Standards (Trial)" of the National Pharmacopoeia Commission (hereinafter referred to as the "Administrative Measures"), after publicly soliciting project proposals and undertaking units, organizing professional committees and expert groups for review, online publication, and review by the Pharmacopoeia Commission, The task of raising national drug standards in 2021 has been determined
.
The 2021 National Drug Standards Improved Variety and General Technical Requirements Catalogue (see Annex 1 and 2 for details) is hereby fed back to you
1.
Strictly implement the management measures, follow the work tasks, research objectives, evaluation indicators, and budgets determined in the "National Drug Standards Revision Research Project Contract" and its annexes to ensure the progress of the work and strictly control the quality of the work
2.
The drafting unit, the review unit and the lead unit respectively fill in the corresponding electronic and paper contracts according to the nature of the funding (see Annex 3 and 4 for details).
Among them, the type of funding A is for the project funding allocated by the National Pharmacopoeia Commission, and the type B is Funds for the undertaking unit to solve the problem by itself
.
Please send the electronic version of the contract according to the category to the corresponding office contact email address before March 15, 2021
.
After passing the review and informing your unit, please send the paper contract with the official seal of the unit to the corresponding office according to the category
Contacts and methods of each room are as follows:
Chinese Medicine Department:
Gao Jie (010-67079627; gaojie@chp.
Chemical and Drug Office:
Zeng Yi (010-67079553; zengyi@chp.
Department of Biological Products:
Zhao Xiong (010-67079598; zhaoxiong@chp.
Business Integration Office:
Wang Hanzhen (010-67079521; wanghanzhen@chp.
Mailing address: Building 11, Fahua South Lane, Dongcheng District, Beijing (Zip Code: 100061)
National Pharmacopoeia Committee
March 10, 2021
▍ 2021 National Drug Standards Improvement Project List (Variety)
▍ 2021 National Drug Standards Improvement Project List (General Technical Methods)
